Cite

HARVARD Citation

    Weycker, D. et al. (2017). Risk of chemotherapy-induced febrile neutropenia by day of pegfilgrastim prophylaxis in US clinical practice from 2010 to 2015. Current medical research and opinion. pp. 2107-2113. [Online]. 
  
Back to record